Strategies to Limit Project Timeline and Cost in Medical Devices

Developing medical devices under a quality management system for the FDA can be a complicated and subtle process with tremendous variability. The leading mitigatable risk to budget and schedule comes from minimizing the impact of change during the development process. This presentation will address common categories of change and how to minimize or even benefit from the disruption.

The Future of Quality and Regulatory for SaMD

Join industry experts from ICS and Greenlight Guru to discuss recent updates and changes in SaMD, regulatory and quality considerations in growing technologies including AI, mobile and cloud and three steps to take today to prepare for the future.